These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30084992)

  • 1. Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial.
    Sunde B; Johnsen G; Jacobsen AB; Glenjen NI; Friesland S; Lindblad M; Rouvelas I; Wang N; Lundell L; Lagergren P; Nilsson M
    Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30084992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
    Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial).
    Sunde B; Klevebro F; Johar A; Johnsen G; Jacobsen AB; Glenjen NI; Friesland S; Lindblad M; Ajengui A; Lundell L; Lagergren P; Nilsson M
    Br J Surg; 2019 Oct; 106(11):1452-1463. PubMed ID: 31436322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
    Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
    Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis.
    Jing SW; Qin JJ; Liu Q; Zhai C; Wu YJ; Cheng YJ; Czito BG; Wang J
    Future Oncol; 2019 Jul; 15(20):2413-2422. PubMed ID: 31269806
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
    Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
    Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.
    Noordman BJ; Verdam MGE; Lagarde SM; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch OR; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Spillenaar Bilgen EJ; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB
    J Clin Oncol; 2018 Jan; 36(3):268-275. PubMed ID: 29161204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review.
    Ahmed O; Bolger JC; O'Neill B; Robb WB
    Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 31828290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
    Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
    Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
    Borggreve AS; Mook S; Verheij M; Mul VEM; Bergman JJ; Bartels-Rutten A; Ter Beek LC; Beets-Tan RGH; Bennink RJ; van Berge Henegouwen MI; Brosens LAA; Defize IL; van Dieren JM; Dijkstra H; van Hillegersberg R; Hulshof MC; van Laarhoven HWM; Lam MGEH; van Lier ALHMW; Muijs CT; Nagengast WB; Nederveen AJ; Noordzij W; Plukker JTM; van Rossum PSN; Ruurda JP; van Sandick JW; Weusten BLAM; Voncken FEM; Yakar D; Meijer GJ;
    BMC Cancer; 2018 Oct; 18(1):1006. PubMed ID: 30342494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
    Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
    Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Results of Temporary Placement of Retrievable Expandable Metallic Stents during Preoperative Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer.
    Park JH; Song HY; Shin JH; Kim JH; Kim YH; Kim SB; Kim JH
    J Vasc Interv Radiol; 2015 Jun; 26(6):883-8. PubMed ID: 25724088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Zhang Z; Zhang H
    Dis Esophagus; 2017 Apr; 30(4):1-7. PubMed ID: 28375486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
    Valkema MJ; Spaander MCW; Boonstra JJ; van Dieren JM; Hazen WL; Erkelens GW; Holster IL; van der Linden A; van der Linde K; Oostenbrug LE; Quispel R; Schoon EJ; Siersema PD; Doukas M; Eyck BM; van der Wilk BJ; van der Sluis PC; Wijnhoven BPL; Lagarde SM; van Lanschot JJB
    Br J Surg; 2023 Sep; 110(10):1381-1386. PubMed ID: 37418342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging
    Beukinga RJ; Hulshoff JB; Mul VEM; Noordzij W; Kats-Ugurlu G; Slart RHJA; Plukker JTM
    Radiology; 2018 Jun; 287(3):983-992. PubMed ID: 29533721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer.
    Zhu Y; Liu M; Yun X; Wang D; Bai Y; Zhang G; Ji B; Jing C
    Pathol Oncol Res; 2017 Jul; 23(3):657-663. PubMed ID: 28013492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
    Malthaner RA; Yu E; Sanatani M; Lewis D; Warner A; Dar AR; Yaremko BP; Bierer J; Palma DA; Fortin D; Inculet RI; Fréchette E; Raphael J; Gaede S; Kuruvilla S; Younus J; Vincent MD; Rodrigues GB
    Thorac Cancer; 2022 Jul; 13(13):1898-1915. PubMed ID: 35611396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy.
    Siddiqui AA; Sarkar A; Beltz S; Lewis J; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
    Gastrointest Endosc; 2012 Jul; 76(1):44-51. PubMed ID: 22726465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.